Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2012

View Archived Issues

Itraconazole shows promise as an antiangiogenic and antitumor agent

New amatoxin conjugates patented by Heidelberg Pharma

Novel LRRK2 inhibitors prepared at Merck & Co.

Orchid Chemicals & Pharmaceuticals discloses new HDAC6 inhibitors

Japanese researchers synthesize new vitamin D receptor modulators

Novel anticancer agents presented by Kitasato Institute

New OGA inhibitors patented by Summit Corporation

Companies to develop self-injectable treprostinil

NX-1207 prostate cancer trial receives positive interim safety review

MBC Pharma and Maxwell Biotech enter joint venture in metastatic bone disease

FDA approves denosumab in new indication

MorphoSys reports phase Ib/IIa MOR-103 study results

Aradigm's inhaled liposomal ciprofloxacin shows promise in mouse models

First-in-human study of Opal-HIV-Gag(c) terminated

Eliglustat efficacy maintained for 4 years in patients with Gaucher's disease

Astex Pharmaceuticals discontinues amuvatinib development

Navidea Biopharmaceuticals receives NIH grant to develop RIGS agent

EMA committee recommends approval of new apixaban indication

ViroPharma and Halozyme provide update on development of Cinryze/rHuPH20

Sequestosome-1 identified as a biomarker of melanoma

CHMP recommends Constella in IBS-C

NewLink and Dendreon to collaborate on phase II study of combination treatment for prostate cancer

VIVUS anticipates CHMP opinion on Qsiva MAA

CHMP recommends expanded approval of Trajenta tablets

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...